Introduction
Folate deficiency occurs in 20 -30° «-, of patients with severe depression (1) and folate replacement in such patients enhances recovery with antidepressant therapy (2) . Folate deficiency has also been reported to decrease serotonergic activity in man and experimental animals (3) . The mechanism of this effect is unknown but one poossibility is through an effect on tctrahydrobiopterin (BH4) metabolism. Evidence to support this come from studies on patients with a congenital deficiency of 5,10-methylenetetrahydrofolate reductase in which reduced concentrations of CSF BH4 and CSF monoamine metabolites are found (4) . In order to better understand the relationships between folates and monoamines we have undertaken studies to measure red cell and CSF folate and total plasma homocysteine, a sensitive marker of folate deficiency, and CSF monoamine metabolites in patients with severe depression. In some of these patients we also examined CSF BH4
Material and Methods
Blood was obtained from 14 patients with various neurological disorders (i.e. peripheral neuropathy, motor neurone disease, narcolepsy, sciatica and back pain), which formed the neurological control group, and from 59 patients with severe depression having a Hamilton rating score greater than 20. All medication was withdrawn for at least one week prior to sam- pling. Consent was obtained to perform lumbar punctures in 14 neurological control patients and 34 patients in the depressed group. All lumbar punctures were performed between 0900 and 1100 hours in the recumbent position and after over night fasting at the L3-L4 position. 5 ml of CSF was withdrawn and stored at -70 C.
Red blood cell and CSF folate were determined by microbiological assay using L. casei. CSF 3-methoxy-4-hydroxyphenylglycol (MHPG). 5-hydroxyindole acetic acid (5HIAA). homovanillic acid (HVA) and BH4 were determined by HPLC with electrochemical detection.
Results and Discussion
Our results showed that in the depressed group 12 out of 59 patients (20.3%) had red cell folate values less than 150 ng ml and. that 11 out of 34 patients 32.0 oi had CSF folate values less than 15.0 ng/ml. No ne of the patients in the neurological control group had values below these lower limits of our reference range for red cell or CSF folate. These findings are consistent with previous studies indicating an association between folate deficiency (low red cell or serum folate ι and depression ( 1 ). Furthermore, total plasma homocysteine v. as significantly raised (p < 0.01) in the depressed group (mean ± SD 13.7 ± 7.0, η = 54) compared to neurological control group (mean + SD 6.6 ± 2.1. η = 14). In the depressed patients red cell folate and total plasma homocysteine were significantly negatively correlated (r = -0.503; ρ < 0.01, η = 42). The rise in total plasma homocysteine in depressed patients indicates a failure in the methyla- In depressed patients with low red cell folate values (less than 150 ng/ml), CSF 5HIAA levels (mean ± SD, 67.5 ± 23.2 ; η = 7) were significant lower (p < 0.05) compared to the neurological control group (mean ± SD, 107.2 ± 22.6, η = 14). Furthermore, red cell folate was significantly correlated with both CSF 5HIAA (r = 0.432, ρ < 0.02, η = 34) and CSF HVA (r = 0.588, ρ < 0.01, η = 34). In 10 patients with depression, CSF BH4 was significantly correlated with red cell folate (r = 0.75, ρ < 0.02), CSF 5HIAA (r = 0.730, Ρ < 0.02) and CSF HVA (r = 0.911, ρ < 0.01). Depressed patients were also separated into two groups on the basis of those with "normal" total plasma homocysteine levels (less than 12 μπιοΙ/1) and those with raised total plasma homocysteine levels (greater than 12 μπιοΐ/ΐ). The 'depressed subgroup with raised total plasma homocysteine levels had significantly lower levels of all CSF MHPG (p < 0.01), CSF 5HIAA (ρ < 0.001) and CSF HVA (ρ < 0.001) when compared to the neurological control group (Table 1) .
The reduced CSF 5HIAA levels in patients with low red cell folate provide further evidence of a probable influence of folate on serotonin metabolism. The significant reductions in CSF MHPG, 5HIAA and HVA in a subgroup of depressed patients with raised total plasma homocysteine indicate that monoamine metabolism may be more widely affected in folate deficient patients. Noradrenergic, serotonergic and dopaminergic systems share many similar synthetic and degradative enzymes and a reduction in all 3 monoamines may indicate an effect at some common metabolic point. The significant correlations between CSF BH4 and red cell folate provide evidence of a link between folate and biopterin metabolism. BH4 is the rate limiting cofactor in the synthesis of monoamines. An impairment in BH4 metabolism could lead to reduced monoamine synthesis. Although there appears to be a link between folate and biopterin metabolism which may lead to reduced monoamine metabolism, the exact mechanism is not yet clear. Further experimental studies are required in order to elucidate the nature of this mechanism.
